Scoring systems for the evaluation of adnexal masses nature: current knowledge and clinical applications
Por:
Terzic M, Aimagambetova G, Norton M, Della Corte L, Marin-Buck A, Lison J, Amer-Cuenca J, Zito G, Garzon S, Caruso S, Rapisarda A, Cianci A
Ahead of Print:
1 abr 2020
Resumen:
Adnexal masses are a common finding in women, with 20% of them developing at least one pelvic mass during their lifetime. There are more than 30 different subtypes of adnexal tumours, with multiple different subcategories, and the correct characterisation of the pelvic masses is of paramount importance to guide the correct management. On that basis, different algorithms and scoring systems have been developed to guide the clinical assessment. The first scoring system implemented into the clinical practice was the Risk of Malignancy Index, which combines ultrasound evaluation, menopausal status, and serum CA-125 levels. Today, current guidelines regarding female patients with adnexal masses include the application of International Ovarian Tumours Analysis simple rules, logistic regression model 1 (LR1) and LR2, OVERA, cancer ovarii non-invasive assessment of treating strategy, and assessment of Different Neoplasias in the adnexa. In this scenario, the choice of the scoring system for the discrimination between benign and malignant ovarian tumours can be complex when approaching patients with adnexal masses. This review aims to summarise the available evidence regarding the different scoring systems to provide a complete overview of the topic.
Filiaciones:
Terzic M:
Nazarbayev Univ, Sch Med, Dept Med, Astana, Kazakhstan
Univ Med Ctr, Natl Res Ctr Mother & Child Hlth, Dept Obstet & Gynecol, Astana, Kazakhstan
Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA
Aimagambetova G:
Nazarbayev Univ, Sch Med, Dept Biomed Sci, Astana, Kazakhstan
Norton M:
Whittington Hosp, Dept Urogynaecol, London, England
Della Corte L:
Univ Naples Federico II, Sch Med, Dept Neurosci Reprod Sci & Dent, Naples, Italy
Marin-Buck A:
CEU Univ, Univ Cardenal Herrera CEU, Dept Surg, Valencia, Spain
Hosp Prov Castellon, Dept Gynecol, Castellon de La Plana, Spain
Amer-Cuenca J:
CEU Univ, Univ Cardenal Herrera CEU, Dept Med, Valencia, Spain
CB06 03 Carlos III Hlth Inst, CIBER Physiopathol Obes & Nutr CIBERobn, Madrid, Spain
CEU Univ, Univ Cardenal Herrera CEU, Dept Physiotherapy, Valencia, Spain
Zito G:
IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Dept Obstet & Gynecol, Trieste, Italy
Garzon S:
Univ Insubria, Filippo Ponte Hosp, Dept Obstet & Gynecol, Varese, Italy
Caruso S:
Univ Catania, Dept Gen Surg & Med Surg Specialties, Obstet & Gynecol Unit, Via Santa Sofia 78, I-95124 Catania, Italy
Rapisarda A:
Univ Catania, Dept Gen Surg & Med Surg Specialties, Obstet & Gynecol Unit, Via Santa Sofia 78, I-95124 Catania, Italy
Cianci A:
Univ Catania, Dept Gen Surg & Med Surg Specialties, Obstet & Gynecol Unit, Via Santa Sofia 78, I-95124 Catania, Italy
|